◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A

Agilent Technologies Inc (A) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Life Sciences Tools & Services · DATA UPDATED 2026-07-02

Agilent Technologies Inc (A) operates in the Life Sciences Tools & Services industry and is headquartered in Santa Clara, United States with about 18,000 employees. Its market capitalization is roughly $39 billion. In the fiscal year ended 2025-10-31, A reported $6.9B in revenue and $1.3B in net income.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.

Interactive charts & full statements → Open the A valuation workbench →

A Revenue & Earnings History — Annual Income Statement

Income statement	TTM	2025-10-31	2024-10-31	2023-10-31	2022-10-31	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31	2016-10-31	2015-10-31	2014-10-31	2013-10-31	2012-10-31	2011-10-31	2010-10-31	2009-10-31	2008-10-31	2007-10-31	2006-10-31
Total Revenue	$7.2B	$6.9B	$6.5B	$6.8B	$6.8B	$6.3B	$5.3B	$5.2B	$4.9B	$4.5B	$4.2B	$4.0B	$4.0B	$3.9B	$6.9B	$6.6B	$5.4B	$4.5B	$5.8B	$5.4B	$5.0B
Gross Profit	$3.8B	$3.6B	$3.5B	$3.5B	$3.7B	$3.4B	$2.8B	$2.8B	$2.7B	$2.4B	$2.2B	$2.0B	$2.0B	$1.9B	$3.6B	$3.5B	$2.9B	$2.3B	$3.2B	$3.0B	$2.7B
Gross Margin %	53.0%	52.4%	54.3%	50.7%	54.4%	53.9%	53.1%	54.3%	54.7%	53.9%	52.3%	50.5%	48.8%	49.0%	52.5%	53.3%	53.8%	51.1%	55.4%	54.8%	53.4%
Operating Income (EBIT)	$1.6B	$1.5B	$1.5B	$1.4B	$1.6B	$1.3B	$846M	$941M	$904M	$841M	$615M	$522M	$419M	$386M	$1.1B	$1.1B	$566M	$47M	$795M	$584M	$464M
Operating Margin %	21.5%	21.3%	22.9%	19.8%	23.6%	21.3%	15.8%	18.2%	18.4%	18.8%	14.6%	12.9%	10.3%	9.9%	16.3%	16.2%	10.4%	1.1%	13.8%	10.8%	9.3%
Net Income	$1.4B	$1.3B	$1.3B	$1.2B	$1.3B	$1.2B	$719M	$1.1B	$316M	$684M	$460M	$401M	$549M	$724M	$1.2B	$1.0B	$684M	($31M)	$693M	$638M	$3.3B
Net Margin %	19.6%	18.8%	19.8%	18.1%	18.3%	19.1%	13.5%	20.7%	6.4%	15.3%	10.9%	9.9%	13.6%	18.6%	16.8%	15.3%	12.6%	-0.7%	12.0%	11.8%	66.5%
EBITDA	$2.0B	$1.8B	$1.9B	$1.7B	$1.9B	$1.8B	$1.2B	$1.2B	$1.2B	$1.1B	$863M	$799M	$723M	$758M	$1.4B	$1.4B	$1.0B	$257M	$1.1B	$775M	$634M
Earnings Per Share (EPS)	$5.81	$5.58	$5.29	$5.45	$5.21	$4.34	$3.28	$3.12	$2.79	$2.37	$1.98	$1.73	$3.05	$2.89	$3.12	$2.95	$2.00	$0.80	$1.95	$1.55	$1.54
Shares Outstanding (M)	284M	284M	291M	296M	300M	307M	312M	318M	325M	326M	329M	335M	338M	345M	353M	355M	353M	346M	371M	406M	441M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

A Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31
Total Revenue	$1.8B	$1.8B	$1.9B	$1.7B	$1.7B	$1.7B	$1.7B	$1.6B
Gross Profit	$1.0B	$946M	$964M	$914M	$866M	$899M	$916M	$855M
Gross Margin %	55.0%	52.6%	51.8%	52.6%	51.9%	53.5%	53.8%	54.2%
Operating Income (EBIT)	$399M	$353M	$443M	$360M	$300M	$376M	$408M	$333M
Operating Margin %	21.7%	19.6%	23.8%	20.7%	18.0%	22.4%	24.0%	21.1%
Net Income	$339M	$305M	$434M	$336M	$215M	$318M	$351M	$282M
Net Margin %	18.5%	17.0%	23.3%	19.3%	12.9%	18.9%	20.6%	17.9%
EBITDA	$500M	$456M	$540M	$466M	$362M	$467M	$502M	$428M
Earnings Per Share (EPS)	$1.49	$1.36	$1.59	$1.37	$1.31	$1.31	$1.46	$1.32
Shares Outstanding (M)	284M	284M	284M	285M	285M	287M	291M	291M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

A Free Cash Flow History

Cash flow	TTM	2025-10-31	2024-10-31	2023-10-31	2022-10-31	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31	2016-10-31	2015-10-31	2014-10-31	2013-10-31	2012-10-31	2011-10-31	2010-10-31	2009-10-31	2008-10-31	2007-10-31	2006-10-31
Cash from Operations (CFO)	$1.5B	$1.6B	$1.8B	$1.8B	$1.3B	$1.5B	$921M	$1.0B	$1.1B	$889M	$793M	$1.3B	$713M	$1.2B	$1.2B	$1.3B	$712M	$408M	$756M	$969M	$634M
Capital Expenditures (CapEx)	$382M	$407M	$378M	$298M	$291M	$189M	$119M	$156M	$177M	$176M	$139M	$98M	$207M	$195M	$193M	$188M	$119M	$128M	$154M	$154M	$185M
Free Cash Flow (FCF)	$1.1B	$1.2B	$1.4B	$1.5B	$1.0B	$1.3B	$802M	$865M	$910M	$713M	$654M	$1.2B	$506M	$957M	$1.0B	$1.1B	$593M	$280M	$602M	$815M	$449M
FCF Margin %	14.8%	16.6%	21.1%	21.6%	14.9%	20.5%	15.0%	16.8%	18.5%	15.9%	15.6%	30.3%	12.5%	24.6%	15.1%	16.2%	10.9%	6.2%	10.4%	15.0%	9.0%
Dividends Paid	$285M	$282M	$274M	$265M	$250M	$236M	$222M	$206M	$191M	$170M	$150M	$133M	$176M	$156M	$104M	$1.5B	$747M	$1.1B	—	$598M	$2.3B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

A Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31
Cash from Operations (CFO)	$277M	$268M	$545M	$362M	$221M	$431M	$481M	$452M
Capital Expenditures (CapEx)	$93M	$93M	$93M	$103M	$114M	$97M	$93M	$92M
Free Cash Flow (FCF)	$184M	$175M	$452M	$259M	$107M	$334M	$388M	$360M
FCF Margin %	10.0%	9.7%	24.3%	14.9%	6.4%	19.9%	22.8%	22.8%
Dividends Paid	$72M	$72M	$70M	$71M	$70M	$71M	$68M	$68M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

A Balance Sheet History

Balance sheet	MRQ	2025-10-31	2024-10-31	2023-10-31	2022-10-31	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31	2016-10-31	2015-10-31	2014-10-31	2013-10-31	2012-10-31	2011-10-31	2010-10-31	2009-10-31	2008-10-31	2007-10-31	2006-10-31
Total Assets	$13.1B	$12.7B	$11.8B	$10.8B	$10.5B	$10.7B	$9.6B	$9.5B	$8.5B	$8.4B	$7.8B	$7.5B	$10.8B	$10.7B	$10.5B	$9.1B	$9.7B	$7.6B	$7.4B	$7.6B	$7.4B
Cash & Cash Equivalents	$1.8B	$1.8B	$1.3B	$1.6B	$1.1B	$1.5B	$1.4B	$1.4B	$2.2B	$2.7B	$2.3B	$2.0B	$3.0B	$2.7B	$2.4B	$3.5B	$2.6B	$2.5B	$1.4B	$1.8B	$2.3B
Total Liabilities	$5.9B	$6.0B	$5.9B	$4.9B	$5.2B	$5.3B	$4.8B	$4.7B	$4.0B	$3.6B	$3.6B	$3.3B	$5.5B	$5.4B	$5.4B	$4.7B	$6.5B	$5.1B	$4.9B	$4.3B	$3.7B
Total Debt (Short + Long-Term)	$3.4B	$3.4B	$3.4B	$2.8B	$2.8B	$2.8B	$2.4B	$2.4B	$1.8B	$2.0B	$1.9B	$1.7B	$2.8B	$2.7B	$2.4B	$2.2B	$3.7B	$3.1B	$2.3B	$2.2B	$1.6B
Total Shareholders' Equity	$7.1B	$6.7B	$5.9B	$5.8B	$5.3B	$5.4B	$4.9B	$4.7B	$4.6B	$4.8B	$4.2B	$4.2B	$5.3B	$5.3B	$5.2B	$4.3B	$3.2B	$2.5B	$2.6B	$3.2B	$3.7B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive A viewer.

Other Companies in Life Sciences Tools & Services

TMO · Thermo Fisher Scientific — $211 billion
DHR · Danaher Corporation — $135 billion
WAT · Waters Corporation — $37 billion
IQV · IQVIA — $35 billion
MTD · Mettler Toledo — $27 billion
TECH · Bio-Techne — $11 billion
CRL · Charles River Laboratories — $11 billion

All stocks AA →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.